{
  "actions": [
    {
      "acted_at": "2000-05-03", 
      "references": [
        {
          "reference": "CR S3328-3329", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2000-05-03", 
      "committee": "Committee on Health, Education, Labor, and Pensions", 
      "references": [
        {
          "reference": "CR S3329-3331", 
          "type": "text of measure as introduced"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2501-106", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "106", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2000-05-03", 
  "number": "2501", 
  "official_title": "A bill to provide access and choice for use of generic drugs instead of nongeneric drugs under Federal health care programs, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Generic Pharmaceutical Access and Choice for Consumers Act of 2000", 
  "sponsor": {
    "district": null, 
    "name": "Johnson, Tim", 
    "state": "SD", 
    "thomas_id": "00604", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2000-05-03", 
  "subjects": [
    "Armed forces and national security", 
    "Congress", 
    "Crime and law enforcement", 
    "Drug approvals", 
    "Drugs", 
    "Economics and public finance", 
    "Employee health benefits", 
    "Federal aid to health facilities", 
    "Federal employees", 
    "Generic drugs", 
    "Government employees' health insurance", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Indian medical care", 
    "Legislation", 
    "Managed care", 
    "Medicaid", 
    "Medicare", 
    "Medicare managed care", 
    "Military medicine", 
    "Minorities", 
    "Prescription pricing", 
    "Prisoners", 
    "Social welfare", 
    "Veterans' medical care"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2000-05-03", 
    "text": "TABLE OF CONTENTS: Title I: Encouragement of the Use of Generic Drugs Title II: Therapeutic Equivalence Requirements for Generic Drugs Title III: Generic Pharmaceuticals and Medicare Reform Generic Pharmaceutical Access and Choice for Consumers Act of 2000 - Title I: Encouragement of the Use of Generic Drugs - Amends the Public Health Service Act to require each grant or contract entered into under the Act that involves the provision of health care items or services to individuals to include provisions to ensure that, to the extent feasible, any prescriptions provided for under such grant or contract are filled by providing the generic form of the drug involved, unless the nongeneric form of the drug is either specifically ordered by the prescribing provider or requested by the individual for whom the drug is prescribed.Makes similar changes under the Federal Employee Health Benefits program, Medicare program, Medicaid program, and programs affecting Indians, veterans, the uniformed services, and prisoners.Title II: Therapeutic Equivalence Requirements for Generic Drugs - Amends the Federal Food, Drug, and Cosmetic Act to require that for each abbreviated drug application file there shall be a determination as to whether the new drug for which the application is filed is the therapeutic equivalent of a listed drug prior to the approval of the application.Title III: Generic Pharmaceuticals and Medicare Reform - Expresses the sense of the Senate that legislative language requiring, to the extent feasible, a preference for the safe and cost-effective use of generic pharmaceuticals should be considered in conjunction with any legislation that adds a comprehensive prescription drug benefit to the Medicare program."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Generic Pharmaceutical Access and Choice for Consumers Act of 2000", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to provide access and choice for use of generic drugs instead of nongeneric drugs under Federal health care programs, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:42:14-05:00"
}